MRI预测胰腺导管内乳头状黏液性肿瘤恶性的观察者间变异性和诊断性能
这项多中心回顾性研究纳入100例病理证实的胰腺IPMN患者,由8名放射科医生按2017年国际共识指南评估MRI高危征象和担忧特征。高危征象的观察者间一致性为中等至高度(κ=0.70-0.78),担忧特征为一般至高度(κ=0.22-0.80);各医生预测恶性的AUC为0.77-0.84(中位AUC=0.82),经验丰富者评估至少一个高危征象的一致性优于经验较少者(κ=0.77 vs κ=0.69,P<.001)。
要点
- 主胰管≥10 mm、强化壁结节≥5 mm及至少一个高危征象的观察者间一致性分别为κ=0.78、0.70、0.73,属高度一致。
- 担忧特征的观察者间一致性为一般至高度(κ范围0.22-0.80),一致性不如高危征象。
- 各医生预测恶性IPMN的AUC范围为0.77-0.84(中位AUC=0.82),诊断性能良好。
核心结论
- 2017年国际共识指南用于MRI评估恶性胰腺IPMN时,高危征象获得良好诊断性能和高度观察者间一致性,但担忧特征未达到高度一致性;经验丰富者的一致性似乎优于经验较少者。
研究设计与样本
- 多中心回顾性研究纳入100例病理证实的胰腺IPMN患者(77例手术、23例活检),均于2016至2021年间接受增强MRI;由8名完成专科培训的放射科医生(4名经验丰富者[8-20年]、4名经验较少者[1-4年])按2017年指南评估高危征象和担忧特征。
诊断标准与关键数值
- 高危征象中主胰管≥10 mm的观察者间一致性κ=0.78(95%CI:0.75,0.82),强化壁结节≥5 mm为κ=0.70(95%CI:0.66,0.74),至少一个高危征象为κ=0.73(95%CI:0.69,0.76)。
临床应用与阅片要点
- 阅片评估IPMN恶性潜能时,高危征象(主胰管≥10 mm、强化壁结节≥5 mm)的观察者间一致性较好,担忧特征的一致性变异较大(κ范围0.22-0.80)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background The 2017 international consensus guidelines for intraductal papillary mucinous neoplasm (IPMN) of the pancreas are widely used. Purpose To evaluate the interobserver agreement and diagnostic performance of MRI assessment in predicting the malignant potential of IPMN according to radiologists' experience. Materials and Methods This multicenter retrospective study included 100 patients with pathologically proven pancreatic IPMN (77 patients with surgery, 23 patients with biopsy) who underwent contrast-enhanced MRI between 2016 and 2021. Eight post-fellowship radiologists (four more-experienced [8-20 years] and four less-experienced [1-4 years] reviewers) evaluated MRI for high-risk stigmata and worrisome features identified by the most recent 2017 guidelines. Interobserver agreement was determined using Fleiss κ statistics according to radiologist experience. The diagnostic performance for malignant IPMN was assessed using receiver operating characteristic curve analysis. Results Among 100 patients (mean age, 66 years ± 10 [SD]; 57 men), 52 (52%) had malignant IPMN. For high-risk stigmata, interobserver agreement was substantial for main pancreatic duct size of at least 10 mm (κ = 0.78; 95% CI: 0.75, 0.82), enhancing mural nodule of at least 5 mm (κ = 0.70: 95% CI: 0.66, 0.74), and at least one high-risk stigmata (κ = 0.73: 95% CI: 0.69, 0.76). The worrisome features showed fair to substantial interobserver agreement (κ range, 0.22-0.80). More-experienced reviewers demonstrated better agreement in the assessment of at least one high-risk stigmata than less-experienced reviewers (κ = 0.77 vs κ = 0.69, P < .001). The overall diagnostic performance of each reviewer was good for the prediction of malignant pancreatic IPMN (area under the receiver operating characteristic curve [AUC] range, 0.77-0.84; median AUC, 0.82), with substantial agreement (κ = 0.76). Conclusion The 2017 international consensus guidelines enabled good diagnostic performance and substantial interobserver agreement for high-risk stigmata but not worrisome features on the evaluation of the malignant pancreatic IPMN using MRI. Agreement tended to be better among more-experienced reviewers than among less-experienced reviewers. © RSNA, 2023 Supplemental material is available for this article.
引用
- Choi SY, Min JH, Kim JH, et al. Interobserver Variability and Diagnostic Performance in Predicting Malignancy of Pancreatic Intraductal Papillary Mucinous Neoplasm with MRI. Radiology. 2023. PMID: 37489989. doi:10.1148/radiol.222463
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。